These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24477916)

  • 21. Isoflurane sensitizes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to pinacidil.
    Gassmayr S; Stadnicka A; Suzuki A; Kwok WM; Bosnjak ZJ
    Anesthesiology; 2003 Jan; 98(1):114-20. PubMed ID: 12502987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verrucotoxin inhibits KATP channels in cardiac myocytes through a muscarinic M3 receptor-PKC pathway.
    Wang JW; Yazawa K; Hao LY; Onoue Y; Kameyama M
    Eur J Pharmacol; 2007 Jun; 563(1-3):172-9. PubMed ID: 17362922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of C-type natriuretic peptide on spontaneous contraction in gastric antral circular smooth muscle of rat.
    Guo HS; Cui X; Cui YG; Kim SZ; Cho KW; Li ZL; Xu WX
    Acta Pharmacol Sin; 2003 Oct; 24(10):1021-6. PubMed ID: 14531946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast KATP currents modulate myocyte electrophysiology in infarcted hearts.
    Benamer N; Vasquez C; Mahoney VM; Steinhardt MJ; Coetzee WA; Morley GE
    Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1231-9. PubMed ID: 23436329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function.
    Buttgereit J; Shanks J; Li D; Hao G; Athwal A; Langenickel TH; Wright H; da Costa Goncalves AC; Monti J; Plehm R; Popova E; Qadri F; Lapidus I; Ryan B; Özcelik C; Paterson DJ; Bader M; Herring N
    Cardiovasc Res; 2016 Dec; 112(3):637-644. PubMed ID: 27496871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo.
    Umaru B; Pyriochou A; Kotsikoris V; Papapetropoulos A; Topouzis S
    J Pharmacol Exp Ther; 2015 Jul; 354(1):79-87. PubMed ID: 25977483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
    Herring N; Zaman JA; Paterson DJ
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-type natriuretic peptide inhibits L-type Ca2+ current in rat magnocellular neurosecretory cells by activating the NPR-C receptor.
    Rose RA; Anand-Srivastava MB; Giles WR; Bains JS
    J Neurophysiol; 2005 Jul; 94(1):612-21. PubMed ID: 15772242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain natriuretic peptide modulates the delayed rectifier outward K(+) current and promotes the proliferation of mouse Schwann cells.
    Fei XW; Pan CJ; He YL; Fang YJ; Zhuang JL; Mei YA
    J Cell Physiol; 2011 Feb; 226(2):440-9. PubMed ID: 20672326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myorelaxant action of fluorine-containing pinacidil analog, flocalin, in bladder smooth muscle is mediated by inhibition of L-type calcium channels rather than activation of KATP channels.
    Philyppov IB; Golub AА; Boldyriev OI; Shtefan NL; Totska K; Voitychuk OI; Shuba YM
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):585-92. PubMed ID: 26976335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
    Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
    Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against ischemia/reperfusion-induced arrhythmia in anesthetized male rats.
    Gonca E; Bozdogan O
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):403-11. PubMed ID: 20693159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa Expresses a Functional Human Natriuretic Peptide Receptor Ortholog: Involvement in Biofilm Formation.
    Rosay T; Bazire A; Diaz S; Clamens T; Blier AS; Mijouin L; Hoffmann B; Sergent JA; Bouffartigues E; Boireau W; Vieillard J; Hulen C; Dufour A; Harmer NJ; Feuilloley MG; Lesouhaitier O
    mBio; 2015 Aug; 6(4):. PubMed ID: 26307165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-mediated stimulatory effect of atrial natriuretic factor, brain natriuretic peptide, and C-type natriuretic peptide on testosterone production in purified mouse Leydig cells: activation of cholesterol side-chain cleavage enzyme.
    Khurana ML; Pandey KN
    Endocrinology; 1993 Nov; 133(5):2141-9. PubMed ID: 8404664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
    Kaneki H; Kurokawa M; Ide H
    J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular and renal effect of CNAAC: An innovatively designed natriuretic peptide.
    Zhang S; Geng X; Zhao L; Li J; Tian F; Wang Y; Fan R; Feng N; Liu J; Cheng L; Pei J
    Eur J Pharmacol; 2015 Aug; 761():180-8. PubMed ID: 25979857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling.
    Lee SJ; Kim SZ; Cui X; Kim SH; Lee KS; Chung YJ; Cho KW
    Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H208-21. PubMed ID: 10644601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes.
    Tsutsumi Y; Oshita S; Kitahata H; Kuroda Y; Kawano T; Nakaya Y
    Anesthesiology; 2000 Apr; 92(4):1154-9. PubMed ID: 10754636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes.
    Del Ry S; Cabiati M; Vozzi F; Battolla B; Caselli C; Forini F; Segnani C; Prescimone T; Giannessi D; Mattii L
    Peptides; 2011 Aug; 32(8):1713-8. PubMed ID: 21723350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.